Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 11—November 2015
Research

Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010–2013

Kimiko UbukataComments to Author , Naoko Chiba, Shigeo Hanada, Miyuki Morozumi, Takeaki Wajima, Michi Shouji, Satoshi Iwata, and Invasive Pneumococcal Diseases Surveillance Study Group
Author affiliations: Keio University School of Medicine, Tokyo, Japan (K. Ubukata, N. Chiba, M. Morozumi, S. Iwata); Toranomon Hospital, Tokyo (S. Hanada); Tokyo University of Pharmacy and Life Sciences, Tokyo (T. Wajima); National Cancer Center Hospital, Tokyo (M. Shouji)

Main Article

Table 5

Serotypes, resistance genotypes, and multilocus sequence type for non-PCV13 serotype isolates from adults with invasive pneumococcal diseases, Japan, April 2010–March 2013*

Serotype (total no. isolates) No. isolates, N = 92 Penicillin resistance genotype Macrolide resistance gene Clonal complex ST Earliest report of same ST†
Year Country (city)
6C (17) 1 gPISP(pbp2x+2b) erm(B) 315 386 1996 Portugal (Lisbon)
4 gPISP(pbp2x) erm(B) 2924 2924 2003 Japan (Hyogo)
2 gPISP(pbp2x) erm(B) 2924 6183 2008 Japan (Kanagawa)
1 gPISP(pbp2x) erm(B) 2924 9336‡ 2012 Japan (Fukuoka)
1 gPSSP Non 473 473 1994 England (Oxford)
3 gPISP(pbp2x+2b) erm(B) 156 5241 2008 Japan (Kumamoto)
2 gPISP(pbp2x+2b) mef(A) 5832 5025‡ 2012 Japan (Kanagawa)
2 gPISP(pbp2x+2b) mef(A) or erm(B) 5832 5832 2009 Japan (Chiba)

1
gPISP(pbp2x+2b)
mef(A)+erm(B)
5832
5832
2009
Japan (Chiba)
6D (1)
1
gPRSP
mef(A)
81
282
1996; 2008   
Vietnam [23F]; 
South Korea [6D]
10A (11) 1 gPISP(pbp2x) Non 156 1263 1998 USA (Arizona/New Mexico)
1 gPISP(pbp2x) Non 156 3395‡ 2012 Japan (Toyama)
8 gPISP(pbp2x) erm(B) 113 5236 2007 Japan (Kanagawa)

1
gPISP(pbp1a+2x)
erm(B)
113
3078‡
2012
Japan (Yamaguchi)
11A (5) 1 gPSSP mef(A) 99 99 2007 South Korea (Seoul)

4
gPISP(pbp2x)
mef(A)+erm(B)
99
99
2007
South Korea (Seoul)
15A (8) 4 gPISP(pbp1a+2x) erm(B) 63 63 1992 [Sweden15A-25]

4
gPRSP
erm(B)
63
63
1992
[Sweden15A-25]
15B (6) 1 gPSSP mef(A) 199 199 1987 [Netherlands15B-37]
3 gPISP(pbp2x) erm(B) 199 199 1987 [Netherlands15B-37]
1 gPISP(pbp2x) erm(B) 199 5609‡ 2012 Japan (Tokyo)

1
gPRSP
erm(B)
81
83
1997
2007
Taiwan [23F] 
South Korea [15]
15C (4) 1 gPISP(pbp2x) erm(B) 199 199 1987 [Netherlands15B-37]
2 gPISP(pbp1a+2x) erm(B) 199 199 1987 [Netherlands15B-37]

1
gPRSP
erm(B)
81
6138‡
2013
Japan (Tokyo)
16F (1)
1
gPRSP
mef(A)
3117
8351‡
2011
Japan (Mie)
20 (3)
3
gPSSP
erm(B)
4745
4745
2005
China (Wuhan, Hubei)
22F (18) 1 gPSSP Non 433 433 1997 Poland (center)
4 gPISP(pbp2x) Non 433 433 1997 Poland (center)
10 gPISP(pbp2x) mef(A) or erm(B) 433 433 1997 Poland (center)
1 gPISP(pbp2x) mef(A) 113 5236 2007 Japan (Kanagawa)

2
gPISP(pbp2x)
erm(B)
113
7158
2007
Japan (Aichi)
23A (9) 2 gPISP(pbp2x+2b) erm(B) 156 338 1995 [Colombia23F-26]
4 gPISP(pbp2x+2b) erm(B) 156 5242 2009 Japan (Kumamoto)
2 gPISP(pbp2x+2b) erm(B) 156 5246 2008 Japan (Niigata)

1
gPRSP
erm(B)
156
9619‡
2011
Japan (Toyama)
35B (9) 2 gPSSP erm(B) 1816 2755 2004 China (Shanghai)
2 gPISP(pbp2x) mef(A) or erm(B) 1816 2755 2004 China (Shanghai)
1 gPRSP Non 558 558 1999 USA (New York) [35B]
4 gPRSP mef(A) or erm(B) 558 558 1999 USA (New York) [35B]

*PCV13, 13-valent pneumococcal conjugate vaccine; ST, sequence type. Brackets in final column represent clones reported in the Pneumococcal Molecular Epidemiology Network Clone Collection (http://web1.sph.emory.edu/PMEN/index.html).
†Earliest year and first location are shown for the applicable ST registered in the Multilocus Sequence Typing website (http://spneumoniae.mlst.net).
Identified as a new ST in this study.

Main Article

Page created: October 16, 2015
Page updated: October 16, 2015
Page reviewed: October 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external